Index
A
AcGQCy7, 189
Aggregation-induced emission (AIE), 185, 189,
192, 198
Alexa-647, 42
Amino acids, 153, 158, 214
unnatural (UAAs), 162
Animal imaging, 171
Antibodies, 18, 57, 73, 85, 197, 214, 217
conjugates, 41
Anti-Stokes shift luminescence, 60
Aptamers, 58
Asialoglycoprotein receptor (ASGPR), 197
Au nanoclusters (AuNCs), 63
nanoparticles, 64, 129–144, 217
Autofluorescence, 4, 35, 45, 58, 82, 89, 100,
117, 123, 136, 174, 194, 203, 212
endoscopy (AFE), 206
Autofluorescent protein (AFP), 153
B
Bacteria, coliform, 192
imaging, 45
infections, 171
Benzobisthiadiazole (BBTD), 6
β-Galactosidase, 185
Bimolecular fluorescent complementation
(BiFC) sensors, 160
Bioluminescence, 102, 186, 215, 217
proteins, 149
BODIPY, 4, 19, 35–38, 45, 47
Boundary element method (BEM), 14
Breast cancer, 8, 16, 37, 39, 63, 99, 135, 211,
213, 217
BRET, 149
C
CA19-9, 214
Cadmium-zinc-telluride (CZT) crystals, 129
Calcium, ions, 161
sensors, 154, 164
Calcium phosphate nanoparticles (CPNPs), 70
Camptothecin, 20
Cancer imaging, 45, 188, 215
Candidate drug screening, 2
Carbon dots (C-dots), 63
Carbonic anhydrases IX (CAIX), 10
Carbon quantum dots (CQDs), 196
Carcinoembryonic antigen (CEA), 41, 214
Caspase, 167, 168
CdSe, 56
Cerenkov luminescence imaging (CLI),
203, 209, 215
Cerenkov radiation energy transfer
(CRET), 217
CH1055, 84
Chromoproteins, 154
Cisplatin, 20, 130
Claudin-1-IRDye800CW, 41
Claudins, 41
Clinical imaging, 203
Coded-aperture compressive XLCT
(CAC-XLCT), 141
Colorectal cancer/tumors, 10, 211
225
A
AcGQCy7, 189
Aggregation-induced emission (AIE), 185, 189,
192, 198
Alexa-647, 42
Amino acids, 153, 158, 214
unnatural (UAAs), 162
Animal imaging, 171
Antibodies, 18, 57, 73, 85, 197, 214, 217
conjugates, 41
Anti-Stokes shift luminescence, 60
Aptamers, 58
Asialoglycoprotein receptor (ASGPR), 197
Au nanoclusters (AuNCs), 63
nanoparticles, 64, 129–144, 217
Autofluorescence, 4, 35, 45, 58, 82, 89, 100,
117, 123, 136, 174, 194, 203, 212
endoscopy (AFE), 206
Autofluorescent protein (AFP), 153
B
Bacteria, coliform, 192
imaging, 45
infections, 171
Benzobisthiadiazole (BBTD), 6
β-Galactosidase, 185
Bimolecular fluorescent complementation
(BiFC) sensors, 160
Bioluminescence, 102, 186, 215, 217
proteins, 149
BODIPY, 4, 19, 35–38, 45, 47
Boundary element method (BEM), 14
Breast cancer, 8, 16, 37, 39, 63, 99, 135, 211,
213, 217
BRET, 149
C
CA19-9, 214
Cadmium-zinc-telluride (CZT) crystals, 129
Calcium, ions, 161
sensors, 154, 164
Calcium phosphate nanoparticles (CPNPs), 70
Camptothecin, 20
Cancer imaging, 45, 188, 215
Candidate drug screening, 2
Carbon dots (C-dots), 63
Carbonic anhydrases IX (CAIX), 10
Carbon quantum dots (CQDs), 196
Carcinoembryonic antigen (CEA), 41, 214
Caspase, 167, 168
CdSe, 56
Cerenkov luminescence imaging (CLI),
203, 209, 215
Cerenkov radiation energy transfer
(CRET), 217
CH1055, 84
Chromoproteins, 154
Cisplatin, 20, 130
Claudin-1-IRDye800CW, 41
Claudins, 41
Clinical imaging, 203
Coded-aperture compressive XLCT
(CAC-XLCT), 141
Colorectal cancer/tumors, 10, 211
225
